Platinum Investment Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,612
| Closed | -$1.19M | – | 152 |
|
|
2023
Q1 | $1.19M | Hold |
11,612
| – | – | 0.04% | 96 |
|
|
2022
Q4 | $1.7M | Hold |
11,612
| – | – | 0.06% | 85 |
|
|
2022
Q3 | $1.96M | Sell |
11,612
-8,207
| -41% | -$1.39M | 0.08% | 77 |
|
|
2022
Q2 | $2.29M | Hold |
19,819
| – | – | 0.09% | 78 |
|
|
2022
Q1 | $1.98M | Hold |
19,819
| – | – | 0.06% | 84 |
|
|
2021
Q4 | $3.08M | Buy |
19,819
+15,383
| +347% | +$2.39M | 0.09% | 79 |
|
|
2021
Q3 | $1.05M | Hold |
4,436
| – | – | 0.03% | 116 |
|
|
2021
Q2 | $1.51M | Hold |
4,436
| – | – | 0.03% | 106 |
|
|
2021
Q1 | $1.79M | Hold |
4,436
| – | – | 0.04% | 92 |
|
|
2020
Q4 | $2.95M | Hold |
4,436
| – | – | 0.07% | 73 |
|
|
2020
Q3 | $2.07M | Hold |
4,436
| – | – | 0.05% | 79 |
|
|
2020
Q2 | $2.6M | Buy |
+4,436
| New | +$2.6M | 0.06% | 74 |
|